Ticker: AFMD
Affimed NV
$3.46
(+27.21%)
Since 2019
$
Real time stock price updated as of October 19, 2020, 4:00 PM
The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.
Invest in Affimed NV on Stash
Affimed N.V.
Thanks to fractional shares
Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance.
Read more
Historical stock performance
Last 1 week | -3.27% |
Last 1 month | -6.58% |
Last 12 months | 23.26% |
Last 3 years | 18.19% |
Last 5 years | -14.05% |
Last 10 years | -- |
Last 15 years | -- |
Since inception | -7.59% |
The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.
Affimed NV stock News
This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites.
CNBC
about 6 hours ago
Airline shares jump after TSA screenings topped 1 million, a 7-month high
U.S. airline stocks rose sharply on Monday after airport screenings topped 1 million in a single day.
24/7 Wall Street
about 2 hours ago
IBM Earnings Just Can't Cut It
International Business Machines Corp. (NYSE: IBM) reported third-quarter financial results after markets closed Monday.
See It Market
about 21 hours ago
These 6 Stock Market ETFs Are Cheering On The Bull Market
In spite of no passing government stimulus, mixed economic data, rising covid cases and a wild pre election season, for the first time since we can remember, our core stock market ETFs are brushing off most of the negativity.
CNBC
about 2 hours ago
IBM reports third straight quarter of revenue declines
Revenue declines have returned under new IBM CEO Arvind Krishna as he seeks to sell off part of the company's largest business segment.
Why invest on Stash?
Invest affordably.
You can buy pieces of stocks and funds with any dollar amount—and our subscription plans start at just $1 per month.
Enjoy unlimited trading.
Unlike other investing apps, Stash also doesn't charge any add-on trading commissions or electronic statement fees.1
Learn how to invest.
We'll help teach you how to invest confidently through tips, articles, and ongoing personalized guidance.
Stay diversified.
We can help guide you through building a custom balanced portfolio with our
1Stash may incur ancillary fees charged by Stash and/or its custodian that are not included in the monthly Wrap-Fee.
How to buy Affimed NV stock on Stash
1. Enter the amount you'd like to invest in Affimed NV stock, then proceed to checkout.
Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
Read more
2. Choose a Stash plan and set up your investment account in just a few minutes.
Stash offers three subscription plans: Stash Beginner, Stash Growth, and Stash+. Our Beginner plan starts at just $1 per month.
Read more
3. Once you’ve finished your account, your Affimed NV shares will be added to your new portfolio.
Once your market order of Affimed NV stock is complete, you'll officially be a shareholder of Affimed NV!
Read more
Invest in Affimed NV on Stash
Affimed N.V.
Thanks to fractional shares
Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance.
Read more
Stash resources for confident investing
How to Start Investing
Getting started in the world can be intimidating. Take a look at some of these basics we put together so you can learn how to start investing.
Investing in Fractional Shares on Stash
Good news: Learn how fractional shares can make an investment a lot more affordable.
Here’s How to Research Stocks
Consider P/E ratio, profit and loss, and news when buying stocks.
Subscribe to The Wallet!
Looking for financial guidance? Check your Wallet. Every week, your inbox will be packed with market savviness and clever money management techniques. Sign up today!
More Health Care stocks
BTAI
BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company that is focused on the development of drugs for psychiatric disorders and rare cancers.
BDTX
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. is a precision oncology medicine company.
GSK
Glaxosmithkline PLC
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines.
CDMO
Avid Bioservices Inc
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO).
CLSN
Celsion Corp
Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study).
VYGR
Voyager Therapeutics Inc
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company.
147k+ reviews on App Store and Google Play™ Store
Over 3 million Americans use Stash to invest, save, and spend.
This is not an endorsement or a statement of satisfaction.
